Levi & Korsinsky Alerts Geron Corporation Investors of Class Action Lawsuit

Investors who have purchased shares in Geron Corporation are being notified by Levi & Korsinsky of a class action lawsuit that has been filed against the company. This legal action and the impending deadline for affected investors have been brought to public attention to ensure that those with a stake in the corporation are aware of the situation. The class-action lawsuit aims to represent individuals who acquired shares in Geron Corporation between March 19, 2018, and September 26, 2018.

The lawsuit alleges that Geron Corporation issued false and misleading statements about the results from the clinical drug trials of imetelstat, one of the company’s key products. These inaccurate statements are said to have artificially inflated the value of Geron Corporation’s stock during the mentioned period, leading investors to suffer financial losses as a result. The legal action further claims that Geron Corporation failed to disclose crucial information regarding the development of imetelstat, which would have impacted investor decisions had it been made known.

Following this news, the value of Geron Corporation’s shares experienced a significant decline in response to the revelation of the alleged false statements. Due to these developments, investors who purchased shares in the company during the specified timeframe may have incurred financial losses as a result of relying on inaccurate information provided by Geron Corporation about the performance of imetelstat in clinical trials.

Investors who meet the criteria outlined for participation in the class-action lawsuit are encouraged to take appropriate steps to protect their legal rights and interests. It is essential for affected individuals to be aware of their rights and options in light of the allegations made against Geron Corporation, as well as the potential repercussions for their investments resulting from the company’s purported actions.

Levi & Korsinsky, a well-known law firm specializing in representing investors in securities litigation, is currently investigating the claims made against Geron Corporation and is prepared to pursue legal action on behalf of affected shareholders. The firm’s involvement in this matter underscores the seriousness of the allegations against Geron Corporation and the importance of holding the company accountable for its actions, as well as seeking restitution for investors who have suffered financial losses due to the alleged misconduct.

In conclusion, investors who have purchased shares in Geron Corporation during the specified period are urged to stay informed about the developments regarding the class-action lawsuit and to take any necessary steps to protect their legal interests. The allegations of false and misleading statements by Geron Corporation highlight the potential risks that investors face when relying on inaccurate information provided by companies about their financial performance and prospects. By remaining vigilant and seeking appropriate legal counsel, affected investors can ensure that their rights are upheld and that they have the opportunity to pursue recourse for any losses they may have suffered as a result of the alleged misconduct by Geron Corporation.